Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 4
R&D Momentum
90/100
Pipeline Velocity
68/100
Trial Completion Rate
82/100
Pipeline Concentration
22/100
Pipeline Freshness
78/100
Strategic Signals
Activity
Last 14 days
The Effect of High Intensity Interval Training and Surgical Weight Loss on Distal Symmetric Polyneuropathy Outcomes
Effects of Home-based TEA for Abdominal Pain in Patients With Irritable Bowel Syndrome (IBS)
A Multifaceted Adaptive Mobile Application to Promote Self-management and Improve Outcomes in Heart Failure
Controlling Locomotion Over Continuously Varying Activities for Agile Powered Prosthetic Legs
Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers
Mi-SPA: Michigan Split-belt Adaptation Paradigm to Improve Knee Loading After Anterior Cruciate Ligament Reconstruction (Aim 3)
Algorithm-informed Decision-making to Advance Pain Treatment (ADAPT Study)
Noninvasive Thalamocortical Neuromodulation With Low-Intensity Focused Ultrasound for Persistent Developmental Stuttering
Telerehabilitation for Post-Stroke Hand Function
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)